206 related articles for article (PubMed ID: 34274600)
1. Neural mechanisms and predictors of SSRI and CBT treatment of anxiety: A randomized trial focused on emotion and cognitive processing.
Kinney KL; Burkhouse KL; Chang F; MacNamara A; Klumpp H; Phan KL
J Anxiety Disord; 2021 Aug; 82():102449. PubMed ID: 34274600
[TBL] [Abstract][Full Text] [Related]
2. Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial.
Gorka SM; Young CB; Klumpp H; Kennedy AE; Francis J; Ajilore O; Langenecker SA; Shankman SA; Craske MG; Stein MB; Phan KL
Neuropsychopharmacology; 2019 Aug; 44(9):1639-1648. PubMed ID: 31060042
[TBL] [Abstract][Full Text] [Related]
3. Neural Responsiveness to Reward as an Index of Depressive Symptom Change Following Cognitive-Behavioral Therapy and SSRI Treatment.
Burkhouse KL; Gorka SM; Klumpp H; Kennedy AE; Karich S; Francis J; Ajilore O; Craske MG; Langenecker SA; Shankman SA; Hajcak G; Phan KL
J Clin Psychiatry; 2018 Jun; 79(4):. PubMed ID: 29894598
[TBL] [Abstract][Full Text] [Related]
4. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety.
Strawn JR; Mills JA; Suresh V; Peris TS; Walkup JT; Croarkin PE
J Affect Disord; 2022 Feb; 298(Pt A):292-300. PubMed ID: 34728290
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
[TBL] [Abstract][Full Text] [Related]
6. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
Rosnick CB; Wetherell JL; White KS; Andreescu C; Dixon D; Lenze EJ
J Consult Clin Psychol; 2016 Apr; 84(4):345-52. PubMed ID: 26881447
[TBL] [Abstract][Full Text] [Related]
8. Neural Reactivity to Angry Faces Predicts Treatment Response in Pediatric Anxiety.
Bunford N; Kujawa A; Fitzgerald KD; Swain JE; Hanna GL; Koschmann E; Simpson D; Connolly S; Monk CS; Phan KL
J Abnorm Child Psychol; 2017 Feb; 45(2):385-395. PubMed ID: 27255517
[TBL] [Abstract][Full Text] [Related]
9. Neural correlates of emotional reactivity predict response to cognitive-behavioral therapy in obsessive-compulsive disorder.
Paul S; Kathmann N; Elsner B; Reuter B; Barnow S; Simon D; Endrass T; Klawohn J
J Affect Disord; 2022 Jul; 308():398-406. PubMed ID: 35427712
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-analysis.
Arnardóttir A; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):118-126. PubMed ID: 35507829
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
12. Nucleus accumbens volume as a predictor of anxiety symptom improvement following CBT and SSRI treatment in two independent samples.
Burkhouse KL; Jagan Jimmy ; Defelice N; Klumpp H; Ajilore O; Hosseini B; Fitzgerald KD; Monk CS; Phan KL
Neuropsychopharmacology; 2020 Feb; 45(3):561-569. PubMed ID: 31756730
[TBL] [Abstract][Full Text] [Related]
13. 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).
Piacentini J; Bennett S; Compton SN; Kendall PC; Birmaher B; Albano AM; March J; Sherrill J; Sakolsky D; Ginsburg G; Rynn M; Bergman RL; Gosch E; Waslick B; Iyengar S; McCracken J; Walkup J
J Am Acad Child Adolesc Psychiatry; 2014 Mar; 53(3):297-310. PubMed ID: 24565357
[TBL] [Abstract][Full Text] [Related]
14. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
[TBL] [Abstract][Full Text] [Related]
15. Working Memory Load and Negative Picture Processing: Neural and Behavioral Associations With Panic, Social Anxiety, and Positive Affect.
MacNamara A; Jackson TB; Fitzgerald JM; Hajcak G; Phan KL
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Feb; 4(2):151-159. PubMed ID: 29805056
[TBL] [Abstract][Full Text] [Related]
16. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
[TBL] [Abstract][Full Text] [Related]
17. Reduced Reward Responsiveness Predicts Change in Depressive Symptoms in Anxious Children and Adolescents Following Treatment.
Kujawa A; Burkhouse KL; Karich SR; Fitzgerald KD; Monk CS; Phan KL
J Child Adolesc Psychopharmacol; 2019 Jun; 29(5):378-385. PubMed ID: 31062997
[No Abstract] [Full Text] [Related]
18. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
Vitiello B; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes TL; DeBar L; Lynch F; Dickerson J; Strober M; Suddath R; McCracken JT; Spirito A; Onorato M; Zelazny J; Porta G; Iyengar S; Brent DA
J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
[TBL] [Abstract][Full Text] [Related]
20. Brain-behavioral adaptability predicts response to cognitive behavioral therapy for emotional disorders: A person-centered event-related potential study.
Stange JP; MacNamara A; Kennedy AE; Hajcak G; Phan KL; Klumpp H
Neuropsychologia; 2020 Aug; 145():106408. PubMed ID: 28648570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
